Item 8.01. Other Events.




On May 22, 2020, Boston Properties, Inc. (the "Company") and Boston Properties Limited Partnership, the Company's operating partnership (the "Partnership"), filed an automatic shelf registration statement on Form S-3 (File No.

333-

238607

) (the "Universal Shelf Registration Statement") with the Securities and Exchange Commission (the "SEC") to replace an existing shelf registration statement, which was scheduled to expire on June 2, 2020. In connection with the filing of this new registration statement, the Company also filed two new prospectus supplements. These prospectus supplements relate to (i) the Company's new $600 million "at the market" equity offering program as described below, which replaced the Company's prior $600 million "at the market" equity offering program that was scheduled to expire on June 2, 2020, and which is no longer effective, and (ii) the issuance of up to 256,073 shares of common stock of the Company that may be issued from time to time if, and to the extent that, the holders of previously issued common units of limited partnership interest in the Partnership present such units for redemption, which offerings had been covered by the prior registration statement. In addition, on May 22, 2020, the Company filed an automatic shelf registration statement on Form S-3 (File No.

333-

238620


) with the SEC to replace an existing shelf registration statement relating to
its Dividend Reinvestment and Stock Purchase Plan, which was scheduled to expire
on August 4, 2020.
In connection with the commencement of the "at the market" equity offering, the
Company may sell up to an aggregate of $600 million of shares of its common
stock (the "Shares") from time to time during a period of up to three years in
"at the market" equity offerings or certain other transactions (the
"Offering"). The Company may sell the Shares in amounts and at times to be
determined by the Company from time to time, but has no obligation to sell any
of the Shares in the Offering. Actual sales will depend on a variety of factors
to be determined by the Company from time to time, including (among others)
market conditions, the trading price of the Company's common stock, capital
needs and determinations by the Company of the appropriate sources of funding
for the Company.
The Offering will occur pursuant to ten separate sales agency financing
agreements (each, individually, a "Sales Agreement" and, collectively, the
"Sales Agreements") entered into by the Company with each of BofA Securities,
Inc., BNY Mellon Capital Markets, LLC, Deutsche Bank Securities Inc., Jefferies
LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co.
LLC, Scotia Capital (USA) Inc., SunTrust Robinson Humphrey, Inc. and TD
Securities (USA) LLC (and in certain cases, certain of their respective
affiliates) for the offer and sale of the Shares. The Company refers to these
entities, when acting in their capacity as sales agents for the Company or as
principals, each, individually, as a "Sales Agent" and, collectively, as the
"Sales Agents," and when acting in their capacity as agents for the Forward
Purchasers (as defined below), each, individually, as a "Forward Seller" and,
collectively, as the "Forward Sellers."
The Sales Agreements contemplate that, in addition to the issuance and sale of
the Shares by the Company through or to the Sales Agents, acting as its sales
agents or as principals, as applicable, the Company may also engage in forward
sale transactions under separate master forward confirmations (collectively, the
"Master Forward Confirmations") and related supplemental confirmations (each, a
"Forward Sale Agreement" and, collectively, the "Forward Sale Agreements"), with
each of Bank of America, N.A., The Bank of New York Mellon, Deutsche Bank AG,
London Branch, Jefferies LLC, JPMorgan Chase Bank, National Association, Mizuho
Markets Americas LLC, Morgan Stanley & Co. LLC, The Bank of Nova Scotia and The
Toronto-Dominion Bank (and in certain cases, certain of their respective
affiliates). The Company refers to these entities when acting in their capacity
as purchasers under any forward sale transactions, each, individually, as a
"Forward Purchaser" and, collectively, as the "Forward Purchasers."

If the Company decides to engage in a forward sale transaction, it will deliver
instructions to the relevant Forward Purchaser and Forward Seller to borrow and
sell shares of the Company's common stock. Subject to, among other things, the
terms and conditions in the relevant Sales Agreement and the acceptance of such
instructions from the Company by the relevant Forward Purchaser and Forward
Seller, such Forward Purchaser will use its commercially reasonable efforts to
borrow or cause its affiliate to borrow, offer and sell through the relevant
Forward Seller, the applicable shares of the Company's common stock to establish
the initial forward sale price under the applicable Forward Sale Agreement.
Following such sales, pursuant to the relevant Forward Sale Agreement, the
Company generally will have the right during the term of the relevant Forward
Sale Agreement to issue and sell to the relevant Forward Purchaser a number of
shares of the Company's common stock equal to the number of borrowed shares that
were sold in exchange for the forward sale price or, in the sole discretion of
the Company, to cash settle or net share settle the Forward Sale Agreement. At
the end of the term of the relevant Forward Sale Agreement, the Company
generally will be obligated to issue and sell such shares to the relevant
Forward Purchaser for the forward sale price if the Forward Sale Agreement has
not been previously settled. The forward price generally is based on the initial
forward price, as adjusted on a daily basis based on a floating interest rate
factor equal to the overnight bank funding rate less a spread, to be agreed upon
by the Company and the Forward Purchaser under the relevant Forward Sale
Agreement, and subject to decrease on certain dates specified in the relevant
Forward Sale Agreement by the amount per share of quarterly dividends the
Company expects to declare on its common stock during the term of the relevant
Forward Sale Agreement.
Each Sales Agreement has a term of up to three years and provides that the
Company may offer and sell from time to time pursuant to the Sales Agreements up
to a combined total of $600 million of shares of its common stock during such
three-year term through the Sales Agents. The Sales Agreements provide that each
Sales Agent will be entitled to compensation that will not exceed, but may be
lower than, 2.0% of the gross sales price of all shares sold through it as Sales
Agent under the applicable Sales Agreement. In
--------------------------------------------------------------------------------
connection with any Forward Sale Agreement, the Company will pay the applicable
Forward Seller a commission, in the form of a reduced initial forward sale price
under the related Forward Sale Agreement, at a mutually agreed rate not
exceeding 2.0% of the volume-weighted average of the sales prices per share of
the borrowed shares of the Company's common stock sold through such Forward
Seller during the applicable forward hedge selling period for such transaction
(subject to certain adjustments).
Sales of the Shares, if any, pursuant to the Sales Agreements may be made in
transactions that are deemed to be "at the market offerings" as defined in Rule
415 under the Securities Act of 1933, as amended, including sales made directly
on the New York Stock Exchange or sales made to or through a market maker or
through an electronic communications network, as well as in negotiated or other
transactions described in the prospectus supplement relating to the Offering,
which may include block trades. The Company or any of the Sales Agents may at
any time suspend solicitation and offers under the Sales Agreements or terminate
the Sales Agreements.
The Shares will be issued pursuant to the prospectus supplement and the
Universal Shelf Registration Statement described above. The forms of the Sales
Agreements and Master Forward Confirmations are filed as Exhibits 1.1 and 1.2,
respectively, to this Current Report on Form
8-K.
The descriptions of the Sales Agreements and Master Forward Confirmations do not
purport to be complete and are qualified in their entirety by reference to the
forms of the Sales Agreements and Master Forward Confirmations filed herewith as
exhibits to this Current Report on Form
8-K
and incorporated herein by reference.
Opinions of the Company's counsel, Goodwin Procter LLP, regarding the legality
of the shares of common stock covered by the prospectus supplements described
above are filed as Exhibits 5.1 and 5.2 hereto and are incorporated herein by
reference.
This Current Report on Form
8-K
shall not constitute an offer to sell or the solicitation of an offer to buy nor
shall there be any sale of these securities in any state in which such offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state.
Item 9.01. Financial Statements and Exhibits.





(d)
Exhibits
.

 Exhibit
 Number                                      Description

    1.1           Form of Sales Agency Financing Agreement

    1.2           Form of Master Forward Confirmation

    5.1           Opinion of Goodwin Procter LLP regarding the legality of the shares
                offered

    5.2           Opinion of Goodwin Procter LLP regarding the legality of the shares
                offered

   23.1         Consent of Goodwin Procter LLP (included in Exhibits   5.1   and
                  5.2  )

  101.SCH       Inline XBRL Taxonomy Extension Schema Document

  101.CAL       Inline XBRL Taxonomy Extension Calculation Linkbase Document

  101.LAB       Inline XBRL Taxonomy Extension Label Linkbase Document

  101.PRE       Inline XBRL Taxonomy Extension Presentation Linkbase Document

  101.DEF       Inline XBRL Taxonomy Extension Definition Linkbase Document

  104           Cover Page Interactive Data File (formatted as Inline XBRL with
                applicable taxonomy extension information contained in
                Exhibits 101.*)




--------------------------------------------------------------------------------

© Edgar Online, source Glimpses